Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 77.5 +1 (+1.31%) Sep 15
At Loss
P/B:
8.58
Market Cap:
€ 6.95B ($ 8.02B)
Enterprise V:
€ 6.08B ($ 7.02B)
Volume:
0
Avg Vol (2M):
125.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts